2023 - Research.com Biology and Biochemistry in United States Leader Award
1996 - Member of the National Academy of Medicine (NAM)
1995 - Fellow of the American Academy of Arts and Sciences
1993 - Member of the National Academy of Sciences
Member of the Association of American Physicians
Richard D. Klausner spends much of his time researching Biochemistry, Cell biology, Molecular biology, Golgi apparatus and Endoplasmic reticulum. His Biochemistry study which covers Biophysics that intersects with Membrane lipids. His Cell biology research incorporates elements of CD3 Complex, CD3 and Metabolism.
His studies deal with areas such as Von Hippel–Lindau tumor suppressor, T cell, T-cell receptor, Protein subunit and Messenger RNA as well as Molecular biology. He has researched Golgi apparatus in several fields, including GTP' and Endosome. Richard D. Klausner combines subjects such as Cytoplasm, Lysosome and Membrane protein with his study of Endoplasmic reticulum.
His main research concerns Biochemistry, Molecular biology, Cell biology, T-cell receptor and Receptor. His Biochemistry study frequently links to related topics such as Biophysics. His work carried out in the field of Molecular biology brings together such families of science as T cell, Gene, Untranslated region and Tyrosine phosphorylation.
His biological study spans a wide range of topics, including T lymphocyte and Major histocompatibility complex. His research investigates the connection between T-cell receptor and topics such as Antigen that intersect with issues in Antibody. His Receptor research is multidisciplinary, incorporating elements of Cell culture and Transferrin.
His primary scientific interests are in Gene, Biochemistry, Genetics, Cancer research and Cell biology. His Gene study typically links adjacent topics like Molecular biology. His Molecular biology research integrates issues from Von Hippel–Lindau tumor suppressor, Ubiquitin, Ubiquitin ligase, Messenger RNA and Cell fusion.
Richard D. Klausner undertakes interdisciplinary study in the fields of Biochemistry and Multicopper oxidase through his works. His Genetics study integrates concerns from other disciplines, such as Computational biology and Von Hippel–Lindau disease. His study in Cell biology is interdisciplinary in nature, drawing from both RNA, Mutant, Ferritin and Regulatory Pathway.
His scientific interests lie mostly in Gene, Molecular biology, Tumor suppressor gene, Cell cycle and Von Hippel–Lindau tumor suppressor. The study incorporates disciplines such as Necrosis and Somatic cell in addition to Molecular biology. His Tumor suppressor gene research includes themes of Embryo, Cancer research and Endocrinology.
Richard D. Klausner has included themes like Ubiquitin and Ubiquitin ligase in his Von Hippel–Lindau tumor suppressor study. His study on Messenger RNA also encompasses disciplines like
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell Lymphoma
Andreas Rosenwald;George Wright;Wing C. Chan;Wing C. Chan;Joseph M. Connors.
The New England Journal of Medicine (2002)
Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.
Robert L Strausberg;Elise A Feingold;Lynette H Grouse;Jeffery G Derge.
Proceedings of the National Academy of Sciences of the United States of America (2002)
Brefeldin A: insights into the control of membrane traffic and organelle structure.
R D Klausner;J G Donaldson;J Lippincott-Schwartz.
Journal of Cell Biology (1992)
Rapid redistribution of Golgi proteins into the ER in cells treated with brefeldin A: evidence for membrane cycling from Golgi to ER.
Jennifer Lippincott-Schwartz;Lydia C. Yuan;Juan S. Bonifacino;Richard D. Klausner.
Regulating the fate of mRNA: The control of cellular iron metabolism
Richard D. Klausner;Tracey A. Rouault;Joe B. Harford.
Microtubule-dependent retrograde transport of proteins into the ER in the presence of brefeldin A suggests an ER recycling pathway.
Jennifer Lippincott-Schwartz;Julie G. Donaldson;Anja Schweizer;Eric G. Berger.
Molecular Diagnosis of Primary Mediastinal B Cell Lymphoma Identifies a Clinically Favorable Subgroup of Diffuse Large B Cell Lymphoma Related to Hodgkin Lymphoma
Andreas Rosenwald;George Wright;Karen Leroy;Xin-You Yu.
Journal of Experimental Medicine (2003)
Brefeldin A's effects on endosomes, lysosomes, and the TGN suggest a general mechanism for regulating organelle structure and membrane traffic
Jennifer Lippincott-Schwartz;Lydia Yuan;Christopher Tipper;Myléne Amherdt.
The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma
Andreas Rosenwald;George Wright;Adrian Wiestner;Wing C. Chan;Wing C. Chan.
Cancer Cell (2003)
Brefeldin A inhibits Golgi membrane-catalysed exchange of guanine nucleotide onto ARF protein
Julie G. Donaldson;Dario Finazzi;Richard D. Klausner.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: